FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Solco Healthcare US,LLC)

View source ↗

Summary

FDA approved Solco Healthcare US, LLC's lisdexamfetamine dimesylate capsules as an original generic application (ANDA) for ADHD and binge eating disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Binge Eating Disorder

Drugs mentioned

• Lisdexamfetamine dimesylate capsules (lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE CAPSULES)